- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
Limitations on the Capability of the FDA to Advise
American Journal of Bioethics 22 (10):15-17 (2022)
Abstract
Svirsky, Howard, and Berman address the U.S. Food and Drug Administration ’s oversight of tobacco products, the newest major area of regulation Congress assigned to the FDA. They discus...My notes
Similar books and articles
Moral Wrongs, Epistemic Wrongs, and the FDA.Jack Harris - 2022 - American Journal of Bioethics 22 (10):34-37.
Stepping Up or Stepping Back: FDA Roles in Producing and Shaping Knowledge of Pediatric Covid-19 Vaccines.Sophia Bessias & Elizabeth Lanphier - 2022 - American Journal of Bioethics 22 (10):26-28.
Leah Z. Rand, Daniel P. Carpenter, Aaron S. Kesselheim, Anushka Bhaskar, Jonathan J. Darrow, and William B. Feldman Reply. [REVIEW]Leah Z. Rand, Daniel P. Carpenter, Aaron S. Kesselheim, Anushka Bhaskar, Jonathan J. Darrow & William B. Feldman - 2024 - Hastings Center Report 54 (2):44-45.
Additional Steps for Maintaining Public Trust in the FDA.Mitchell Berger - 2024 - Hastings Center Report 54 (2):44-44.
E-Cigarette Use and Regulation: A Comparative Analysis between the United States, the UK, and China.Fengmin Shao, Yue Gu, Lijun Shen, Yuming Wang & Hui Zhang - 2022 - American Journal of Bioethics 22 (10):29-31.
Mifepristone Paternalism at the FDA.Jordan Paradise - 2023 - Journal of Law, Medicine and Ethics 51 (3):554-559.
Ethical Oversight of Direct-to-Consumer Neurotechnologies: The FDA, the FTC, or Self-Regulation?Ishan Dasgupta - 2019 - American Journal of Bioethics Neuroscience 10 (4):200-201.
If Health Care Advertising Is a Problem, FDA-Style Regulation Is Not the Solution.Vanessa Carbonell - 2014 - American Journal of Bioethics 14 (3):46-47.
Blueprint for Transparency at the U.S. Food and Drug Administration: Recommendations to Advance the Development of Safe and Effective Medical Products.Joshua M. Sharfstein, James Dabney Miller, Anna L. Davis, Joseph S. Ross, Margaret E. McCarthy, Brian Smith, Anam Chaudhry, G. Caleb Alexander & Aaron S. Kesselheim - 2017 - Journal of Law, Medicine and Ethics 45 (s2):7-23.
Analytics
Added to PP
2022-09-29
Downloads
16 (#905,992)
6 months
12 (#304,934)
2022-09-29
Downloads
16 (#905,992)
6 months
12 (#304,934)
Historical graph of downloads
Citations of this work
E-Cigarettes, the FDA, Public Health, and Harm Reduction: A Response to the Open Peer Commentaries.Larisa Svirsky, Dana Howard & Micah L. Berman - 2022 - American Journal of Bioethics 23 (1):1-4.
References found in this work
E-Cigarettes and the Multiple Responsibilities of the FDA.Larisa Svirsky, Dana Howard & Micah L. Berman - 2021 - American Journal of Bioethics 22 (10):5-14.
Should Smallpox Vaccine be Made Available to the General Public?Thomas May & Ross D. Silverman - 2003 - Kennedy Institute of Ethics Journal 13 (2):67-82.
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-6686886f5-5pqs9 uwo